SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-119221
Filing Date
2016-05-09
Accepted
2016-05-09 16:15:48
Documents
3
Period of Report
2016-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-10798_18k.htm 8-K 21888
2 EX-99.1 a16-10798_1ex99d1.htm EX-99.1 79394
3 GRAPHIC g107981mmi001.gif GRAPHIC 4233
  Complete submission text file 0001104659-16-119221.txt   108381
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35619 | Film No.: 161631843
SIC: 2834 Pharmaceutical Preparations